Hookipa Pharma (HOOK) Stock Statistics & Valuation Metrics

Hookipa Pharma has a market cap or net worth of $14.06M. The enterprise value is -$19.66M.

Hookipa Pharma has 9,930,789 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hookipa Pharma’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -103.25%.

The current PE Ratio of Hookipa Pharma is ―. Hookipa Pharma’s PEG ratio is 0.01.

In the last 12 months, Hookipa Pharma had revenue of 9.70M and earned -13.84M in profits. Earnings per share was -1.09.

In the last 12 months, operating cash flow was -45.53M and capital expenditures -53.00K, giving a free cash flow of -45.58M billion.

Hookipa Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Hookipa Pharma upcoming earnings date is Aug 7, 2025, TBA (Confirmed).

Hookipa Pharma as a current ratio of 6.35, with Debt / Equity ratio of 1.90%

In the past 12 months, Hookipa Pharma has paid 1.00K in taxes.

Hookipa Pharma EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 2.26.

Hookipa Pharma has $34.23M in cash and marketable securities with $546.00K in debt, giving a net cash position of $33.68M billion.

Gross margin is 100.00%, with operating margin of -376.99%, and net profit margin of -142.63%.

The average price target for Hookipa Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―